Katja Walloe

Q: What is Katja Walloe email address?

Email Katja Walloe at katjaw@mikkelskov.dk and katja@novonordisk.com. This email is the most updated Katja Walloe's email found in 2026.

Q: How to contact Katja Walloe?

To contact Katja Walloe send an email to katjaw@mikkelskov.dk or katja@novonordisk.com. (updated on April 19, 2026)

Director at Ascendis Pharma | Copenhagen, Capital Region of Denmark, Denmark

Profile last verified June 2026

Pharmaceuticals Verified Profile Copenhagen, Capital Region of Denmark, Denmark Københavns Universitet - University of Copenhagen

Katja Walloe’s Email & Phone Number

Verified

Work Email

***@novonordisk.com

Last verified May 2026

Personal Email

***@mikkelskov.dk

Personal • High Confidence

Phone Number

(**) *** *** 741

Denmark • Phone

Free account · No credit card · 5 profiles/month

Katja Walloe Work Experience

Director at Ascendis Pharma in September 2025 - Present

Senior Compliance Officer at Lundbeck in June 2022 - September 2025

Principal R&D Business Ethics Compliance Specialist at Novo Nordisk in September 2018 - June 2022

See more See less

R&D Business Ethics Compliance Specialist at Novo Nordisk in May 2015 - September 2018

Competency Development Manager at Novo Nordisk in September 2014 - May 2015

Competency Development Professional at Novo Nordisk A/S in April 2011 - September 2014

Clinical Trial Administrator at Novo Nordisk A/S in November 2009 - May 2011

Project Assistant PS@SAP at Novo Nordisk in August 2009 - October 2009

Business Analyst at Novo Nordisk in April 2009 - July 2009

Student assistant at Novo Nordisk in February 2007 - March 2009

Katja Walloe Education

Københavns Universitet - University of Copenhagen, Master, July 2026

Katja Walloe Skills

Active Listening Regulatory Requirements Policy Development Workload Prioritization Operating Systems Team Leadership Cooperation Business Development Budgeting Optimization Whistleblower Internal Investigations Information Technology ISO 9001 General Data Protection Regulation (GDPR) Healthcare Business Relationship Management Organizational Leadership Product Management Operations Management Global Talent Acquisition Environment, Health, and Safety (EHS) Key Performance Indicators Change Control Document Management Continuous Improvement User Interface Design Design Thinking Build Strong Relationships Sustainability Mitigation Strategies Environmental, Social, and Governance (ESG) Corporate Governance Collaborative Work Business Integrity Business intelligence Agile development Due diligence Strategiske partnerskaber Contract Negotiation Life Sciences Investigation International Regulations Patient support programs Scientific exchange Good publication practice Policies & procedures Compliance training Business requirements Operationel effektivitet Incident management Coaching Organisationskultur Teamledelse Digital Transformation Kvalitetsstyring Ledelse Process development Operations Processes Business process improvement Forretningskontinuitet Kvalitetsrevision Kvalitetssystem Deviations Compliance management Kvalitetssikring Intern kontrol Stakeholder management Pharmaceutical Industry Clinical Trials Clinical Development Good Clinical Practice (GCP) Project Management Strategy Change Management Standard Operating Procedure (SOP) Analysis GCP Leadership Business Ethics HCP Compliance Forretningsstrategi Medicinalindustrien Kliniske undersøgelser Menneskerettigheder Audit Etik IT-strategi Forandringsledelse Design af forretningsproces Kortlægning af forretningsprocesser Interesseorganisationer Training Kommunikation Strategisk planlægning Analyser Risikostyring Risikovurdering Risikoanalyse Udvikling af menneskelige ressourcer

About Katja Walloe’s Current Company

Ascendis Pharma

Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.

Discover more about Ascendis Pharma

Katja Walloe’s Colleagues

Sune Mejlvang

Gladsaxe, Capital Region of Denmark, Denmark

Digitalization, Value stream optimization, organisational development, Connected health, Product development, Pharmaceutical

VP, Digitalization at Ascendis Pharma
(January 2025 – Present)

***@hotmail.com

(**) *** *** 215

Jan Jakobsgaard

Copenhagen, Capital Region of Denmark, Denmark

Senior Director, QA Operations Drug Substance

Senior Director, QA Operations Drug Substance/QA for QC at Ascendis Pharma
(January 2025 – Present)

***@jakobsgaard.dk

(**) *** *** 404

Adoracion Jurado

Copenhagen, Capital Region of Denmark, Denmark

Associate Director | Global Medical Affairs | Ascendis Pharma

Global Medical Scientist | Associate Director | Global Medical Affairs at Ascendis Pharma
(August 2025 – Present)

***@hotmail.com

(**) *** *** 199

Isabell Jensen

Denmark

SVP, Compliance, Risk & Corporate Responsibility at Ascendis Pharma A/S

Consultant- European Trademark Attorney at Plougmann & Vingtoft
(May 2026 – May 2026)

***@gmail.com

(**) *** *** 122

Tommy Annfeldt

Copenhagen, Capital Region of Denmark, Denmark

Pharmaceutical Innovator & Researcher | Digital Transformation Leader in Medical Affairs | Advancing Healthcare through Strategic Innovation and Scientific Inquiry.

PHD Student at The Parker Institute
(November 2022 – Present)

***@gmail.com

(**) *** *** 218